Manager file · PTNT · Patient Capital Management, LLC
Samantha McLemore - Patient Capital Management
EDGAR CIK 1854794 ↗ · Filed · typical filing lag 44.0 days
Reported portfolio value
$3.15B
QoQ reported +3.1% · vs Q2 2026
Positions
41
4 new · 3 exited
Top 10 concentration
50.4%
largest position 6.3%
Position churn · Q3 2026
5 added · 25 trimmed
new positions 6.6% · exits 0.0% of book
Holdings · Q3 2026 · 41
| Security | Weight | Δ wt | Price* | Shares | Δ shares | Value | Action | |
|---|---|---|---|---|---|---|---|---|
| 1 | — ROYALTY PHARMA PLC | 6.35% | -0.3% | $58 | 3.42M | -4.9% | $200M | Trimmed |
| 2 | C CITIGROUP INC | 5.72% | -0.7% | $129 | 1.39M | -1.0% | $180M | Trimmed |
| 3 | GOOGL ALPHABET INC | 5.67% | -0.5% | $344 | 518K | -1.4% | $178M | Trimmed |
| 4 | AMZN AMAZON COM INC | 5.36% | +0.0% | $249 | 677K | -0.6% | $169M | Trimmed |
| 5 | NVDA NVIDIA CORPORATION | 5.15% | +0.5% | $228 | 710K | +0.0% | $162M | Held |
| 6 | UNH UNITEDHEALTH GROUP INC | 4.97% | -1.0% | $367 | 426K | -2.7% | $156M | Trimmed |
| 7 | PGEN PRECIGEN INC | 4.88% | +1.3% | $9 | 17.95M | -5.7% | $154M | Trimmed |
| 8 | META META PLATFORMS INC | 4.17% | +1.0% | $725 | 181K | +6.0% | $131M | Added |
| 9 | QXO QXO INC | 4.06% | +0.0% | $12 | 10.93M | +53.2% | $128M | Added |
| 10 | CHYM CHIME FINL INC | 4.01% | +1.3% | $27 | 4.73M | +15.9% | $126M | Added |
| 11 | — CALL META PLATFORMS INC | 3.95% | +4.0% | $725 | 172K | new | $124M | New |
| 12 | ET ENERGY TRANSFER L P | 3.79% | -0.0% | $20 | 6.03M | -0.8% | $119M | Trimmed |
| 13 | ADBE ADOBE INC | 3.05% | +0.6% | $240 | 400K | +10.9% | $96.08M | Added |
| 14 | FBTC FIDELITY WISE ORIGIN BITCOIN | 2.82% | +0.8% | $73 | 1.22M | +0.4% | $88.83M | Added |
| 15 | — NORWEGIAN CRUISE LINE HLDGS | 2.78% | -1.4% | $15 | 5.97M | -0.9% | $87.56M | Trimmed |
| 16 | COIN COINBASE GLOBAL INC | 2.74% | +0.5% | $186 | 462K | -0.1% | $86.04M | Held |
| 17 | CROX CROCS INC | 2.73% | -0.4% | $117 | 731K | -8.6% | $85.75M | Trimmed |
| 18 | — SEADRILL LTD | 2.70% | +0.3% | $45 | 1.90M | -2.6% | $84.96M | Trimmed |
| 19 | PPLI PEOPLE INC | 2.67% | -1.0% | $42 | 2.00M | -17.4% | $84.11M | Trimmed |
| 20 | AVGO BROADCOM INC | 2.66% | +2.7% | $351 | 238K | new | $83.74M | New |
| 21 | CVS CVS HEALTH CORP | 2.64% | -1.5% | $86 | 970K | -21.5% | $83.12M | Trimmed |
| 22 | UAL UNITED AIRLS HLDGS INC | 2.53% | -0.7% | $111 | 717K | -2.0% | $79.50M | Trimmed |
| 23 | GPN GLOBAL PMTS INC | 2.43% | +0.2% | $82 | 937K | -0.5% | $76.55M | Trimmed |
| 24 | BIIB BIOGEN INC | 1.77% | -0.2% | $226 | 246K | -13.1% | $55.68M | Trimmed |
| 25 | GM GENERAL MTRS CO | 1.50% | -0.1% | $77 | 613K | -3.0% | $47.18M | Trimmed |
| 26 | EXPE EXPEDIA GROUP INC | 1.40% | -0.0% | $263 | 167K | -0.4% | $44.02M | Trimmed |
| 27 | — CALL BIOGEN INC | 1.36% | +0.0% | $226 | 189K | +0.0% | $42.78M | Held |
| 28 | OMF ONEMAIN HLDGS INC | 1.22% | -0.2% | $55 | 692K | -1.5% | $38.31M | Trimmed |
| 29 | — UBS GROUP AG | 1.08% | -0.5% | $48 | 704K | -26.1% | $33.91M | Trimmed |
| 30 | FISV FISERV INC | 0.97% | -0.6% | $45 | 674K | -29.3% | $30.46M | Trimmed |
| 31 | SOFI SOFI TECHNOLOGIES INC | 0.74% | -0.1% | $16 | 1.49M | -1.3% | $23.36M | Trimmed |
| 32 | DAL DELTA AIR LINES INC | 0.73% | -0.6% | $83 | 276K | -36.0% | $23.04M | Trimmed |
| 33 | TEM TEMPUS AI INC | 0.66% | -0.1% | $82 | 254K | -36.6% | $20.80M | Trimmed |
| 34 | JPM JPMORGAN CHASE & CO | 0.31% | -0.0% | $331 | 29K | -0.0% | $9.71M | Held |
| 35 | — NOBLE CORP PLC | 0.13% | +0.0% | $42 | 100K | +0.0% | $4.17M | Held |
| 36 | JD JD.COM INC | 0.12% | -1.0% | $27 | 139K | -89.9% | $3.70M | Trimmed |
| 37 | APA APA CORPORATION | 0.07% | +0.0% | $42 | 50K | +0.0% | $2.08M | Held |
| 38 | — GENIUS SPORTS LIMITED | 0.04% | -0.1% | $6 | 213K | -73.8% | $1.22M | Trimmed |
| 39 | LEN/B LENNAR CORP | 0.03% | -0.0% | $80 | 12K | +0.0% | $1,000K | Held |
| 40 | — ISHARES TR | 0.01% | +0.0% | $33 | 8,269 | new | $272K | New |
| 41 | — SPDR SERIES TRUST | 0.01% | +0.0% | $96 | 2,709 | new | $260K | New |
| 42 | ILMN ILLUMINA INC | 0.00% | -2.0% | — | 0 | 345K → 0 | $0 | Exited |
| 43 | PLAY DAVE & BUSTERS ENTMT INC | 0.00% | -0.1% | — | 0 | 204K → 0 | $0 | Exited |
| 44 | SPY STATE STR SPDR S&P 500 ETF T | 0.00% | -0.0% | — | 0 | 1,060 → 0 | $0 | Exited |
* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.
This quarter's moves
Filing detail
Period2026-09-30
Accepted12 Nov 2026 · 10:18 ET
Filing lag43 days
Form13F-HR
Information rows41
Quarters on file5
Portfolio value
Quarterly history · 5 filings
export all →
| Quarter | Period end | Reported value | Positions | Largest | New | Exited | Filed | Lag |
|---|---|---|---|---|---|---|---|---|
| Q3 2026 | 2026-09-30 | $3.15B | 41 | 6.3% | 4 | 3 | 12 Nov 2026 ET | 43 |
| Q2 2026 | 2026-06-30 | $3.05B | 40 | 6.6% | 6 | 7 | 13 Aug 2026 ET | 44 |
| Q3 2025 | 2025-09-30 | $2.50B | 41 | 6.0% | 2 | 1 | 29 Oct 2025 ET | 30 |
| Q2 2025 | 2025-06-30 | $2.22B | 40 | 6.4% | 4 | 3 | 13 Aug 2025 ET | 44 |
| Q1 2025 | 2025-03-31 | $1.94B | 39 | 5.6% | — | — | 14 May 2025 ET | 44 |
Track record · return since filing
leaderboard →
Paper return of each reported book
Since Q1 2025
+28.2%
S&P 500 +28.4%
Hit rate · latest book
42%
priced positions with positive return
Priced coverage
86%
of reported stock value
Quarter by quarter
| Quarter | Book | S&P 500 | Excess | Coverage | Best call |
|---|---|---|---|---|---|
| Q3 2026 | -2.1% | -2.0% | -0.2% | 86% | CHYM +4.1% |
| Q2 2026 | -6.4% | -4.3% | -2.1% | 85% | CROX +21.6% |
| Q3 2025 | +5.5% | +10.4% | -4.8% | 85% | ILMN +102.2% |
| Q2 2025 | +8.8% | +16.7% | -7.9% | 84% | ILMN +98.0% |
| Q1 2025 | +28.2% | +28.4% | -0.3% | 85% | BIIB +111.6% |
Copy-trade simulation
Hypothetical strategy
+16.6%
5 rebalances
S&P 500 same window
+28.4%
excess -11.8%
Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.